Concepedia

Terra Potocky

TP

22

Publications

2.1K

Citations

21

H-Index

2003

Active since

Affiliations

Regeneron (United States)(Current)

University of Wisconsin–Madison

Boston College

Progenics Pharmaceuticals (United States)

Sanofi (France)

Terra Potocky is an author at Regeneron (United States) specializing in medicine, immunology, and immunotherapy.

ORCID

Top concepts

Publications per year

2003–2022

22

Publications

22

Dual blockade of IL‐4 and IL‐13 with dupilumab, an IL‐4Rα antibody, is required to broadly inhibit type 2 inflammation

Audrey Le Floc’h, Jeanne Allinne, Kirsten Nagashima et al. · Allergy · 2019 · 448 citations · Full text

Cytoplasmic and Nuclear Delivery of a TAT-derived Peptide and a β-Peptide after Endocytic Uptake into HeLa Cells

Terra Potocky, Anant K. Menon, Samuel H. Gellman · Journal of Biological Chemistry · 2003 · 234 citations · Full text

Development of Clinical-Stage Human Monoclonal Antibodies That Treat Advanced Ebola Virus Disease in Nonhuman Primates

Kristen E. Pascal, Drew Dudgeon, John C. Trefry et al. · The Journal of Infectious Diseases · 2018 · 178 citations · Full text

A class of costimulatory CD28-bispecific antibodies that enhance the antitumor activity of CD3-bispecific antibodies

Dimitris Skokos, Janelle Waite, Lauric Haber et al. · Science Translational Medicine · 2020 · 141 citations

A Mucin 16 bispecific T cell–engaging antibody for the treatment of ovarian cancer

Alison Crawford, Lauric Haber, Marcus P. Kelly et al. · Science Translational Medicine · 2019 · 137 citations · Full text

Rows per page

1–5 of 22